Dark Spots Eraser Pen Solution, Concentrate
NDC Package 84423-087-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dark Spots Eraser Pen solution is formulated with intensive, comprehensive skintone correcting technology including our powerful anti-irritant boosting compound and advanced anti-spot ingredient, 4-Butylresorcinol, Kojic Acid, Lactic Acid, Salicylic Acid, and Morinda Citrifolia extract, this Dark Spots Eraser Pen is the essential core of the Enlighten regimen, It works wonders for both Men and Women of all skin types and is vegan, cruelty-free, and gluten-free. This formulation utilizes a solution, concentrate delivery system. Marketed by Guangzhou Kadiya Biotechnology Co., Ltd., this product is identified by NDC 84423-087 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
84423-087-01
Package Description
20 g in 1 BOTTLE, GLASS
Product Code
84423-087
11-Digit Billing Format
84423008701

Clinical Specifications

Proprietary Name
Dark Spots Eraser Pen
Non-Proprietary Name
Dark Spots Eraser Pen
Substance Name
Kojic Acid; Salicylic Acid
Dosage Form
Solution, Concentrate - A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its nonactive parts.
Administration Route
Cutaneous - Administration to the skin.
Active Ingredient(s)
Usage Information
Formulated with intensive, comprehensive skintone correcting technology including our powerful anti-irritant boosting compound and advanced anti-spot ingredient, 4-Butylresorcinol, Kojic Acid, Lactic Acid, Salicylic Acid, and Morinda Citrifolia extract, this Dark Spots Eraser Pen is the essential core of the Enlighten regimen, It works wonders for both Men and Women of all skin types and is vegan, cruelty-free, and gluten-free.

Regulatory & Marketing

Labeler Name
Guangzhou Kadiya Biotechnology Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-02-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84423-087-01 identifies a specific commercial package of 20 g in 1 bottle, glass of Dark Spots Eraser Pen, a human over the counter drug labeled by Guangzhou Kadiya Biotechnology Co., Ltd.. This solution, concentrate is formulated for cutaneous use and contains kojic acid; salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Kadiya Biotechnology Co., Ltd. on August 02, 2025. The current certification is valid through December 31, 2026.

How is this Guangzhou Kadiya Biotechnology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84423008701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84423-087-01
11-Digit CMS (5-4-2)
84423-0087-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.